AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENETIC SIGNATURES LTD

0.084

+0.0011.20%

Volume:16.56K

Turnover:1K

Market Cap:19.08M

PE:-1.36

High:0.084

Open:0.080

Low:0.080

Close:0.083

52wk High:0.430

52wk Low:0.051

Shares:227.14M

Float Shares:188.02M

Volume Ratio:0.01

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.062

EPS(LYR):-0.062

ROE:-32.64%

ROA:-17.27%

PB:0.53

PE(LYR):-1.36

Loading ...

Overview Company News Filings

Genetic Signatures Reports Decline in Fiscal Q1 Sales

MT Newswires Live

Genetic Signatures - Q1 Fy2027 Sales A$4.0 Mln

THOMSON REUTERS

Genetic Signatures Ltd-Gss Investor Presentation - Proposed Merger with Map

THOMSON REUTERS

Genetic Signatures - Microba Shareholders to Receive 0.654 New Gss Shares Per Microba Share

THOMSON REUTERS

Genetic Signatures - Deal Equates to Issue of 469 Mln New Gss Shares

THOMSON REUTERS

Genetic Signatures - Co and Microba Life Sciences Agree to Principal Commercial Terms for Merger

THOMSON REUTERS

Genetic Signatures - Proposed Merger to be Funded Through Issue of Gss Securities, no Cash Consideration

THOMSON REUTERS

Genetic Signatures - General Meeting for Considering Resolution That Individual be Removed as Director of Co

THOMSON REUTERS

Genetic Signatures - Received a Request from BCAL Diagnostics for Directors of Gss to Call and Arrange General Meeting of Shareholders

THOMSON REUTERS

BCAL Diagnostics - Requests Removal of Michael Aicher and Appointment of Forrester and Melki to Gss Board

THOMSON REUTERS

Genetic Signatures - Requested BCAL Diagnostics to Clarify Details of Its Shareholdings and Associates in Gss

THOMSON REUTERS

Genetic Signatures Ltd-Final Director's Interest Notice

THOMSON REUTERS

Genetic Signatures Announces Board Changes

Genetic Signatures Ltd-Board Changes

THOMSON REUTERS

Genetic Signatures - Caroline Waldron Resigns as Non-Executive Chair and Director Effective Today

THOMSON REUTERS

Genetic Signatures - Mike Aicher Assumes Role of Chair at Genetic Signatures

THOMSON REUTERS

Australia's Genetic Signatures Climbs on Potential Merger with Microba

Genetic Signatures - Combined Group to Benefit from Streamlined Cost Base and Potential Accelerated Growth

THOMSON REUTERS

Genetic Signatures Ltd - FY Revenues from Ordinary Activities A$14.8 Mln

THOMSON REUTERS

Genetic Signatures Ltd-Commercial Testing Commences at Hvidovre Hospital in Denmark

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hkg.itiger.com/stock/GSS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.084,"timestamp":1791522720000,"preClose":0.083,"halted":0,"volume":16561,"delay":0,"changeRate":0.012048192771084347,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.0617,"marketStatus":"Market Closed","change":0.001,"latestTime":"10-09 16:12:00 AEDT","open":0.08,"high":0.084,"low":0.08,"amount":1325,"amplitude":0.048193,"askPrice":0.084,"askSize":14588,"bidPrice":0.079,"bidSize":302616,"shortable":3,"etf":0,"ttmEps":-0.0617,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791759600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.083,"openAndCloseTimeList":[[1791500400000,1791522000000]],"volumeRatio":0.007267543277103073,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.079,"auctionPrice":0.079,"auctionVolume":7125,"auction":3,"marketStatus":"盘后竞价","timestamp":1791435914989}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-17.27%","roe":"-32.64%","lyrEps":-0.0617,"volumeRatio":0.007267543277103073,"shares":227138828,"dividePrice":0,"high":0.084,"amplitude":0.048193,"preClose":0.083,"low":0.08,"week52Low":0.051,"pbRate":"0.53","psRate":"0.99","week52High":0.43,"institutionHeld":0,"latestPrice":0.084,"committee":0.908021,"eps":-0.0617,"divideRate":0,"volume":16561,"delay":0,"ttmEps":-0.0617,"open":0.08,"prevYearClose":0.25,"prevWeekClose":0.079,"prevMonthClose":0.078,"prevQuarterClose":0.078,"fiveDayClose":0.079,"twentyDayClose":0.08,"sixtyDayClose":0.068,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673404560","title":"Genetic Signatures Reports Decline in Fiscal Q1 Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2673404560","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673404560?lang=en_us&edition=fundamental","pubTime":"2026-10-08 12:27","pubTimestamp":1791433628,"startTime":"0","endTime":"0","summary":"Genetic Signatures (ASX:GSS) reported fiscal first-quarter sales of AU$4 million, down from AU$5.4 million a year earlier, according to a Thursday filing with the Australian bourse.Working under a res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673041469","title":"Genetic Signatures - Q1 Fy2027 Sales A$4.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2673041469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673041469?lang=en_us&edition=fundamental","pubTime":"2026-10-08 09:37","pubTimestamp":1791423463,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nFWN45T28T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669993531","title":"Genetic Signatures Ltd-Gss Investor Presentation - Proposed Merger with Map","url":"https://stock-news.laohu8.com/highlight/detail?id=2669993531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669993531?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:46","pubTimestamp":1790034409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUEBVNBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669962981","title":"Genetic Signatures - Microba Shareholders to Receive 0.654 New Gss Shares Per Microba Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2669962981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669962981?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7048","BK7124","MAP.AU","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669297196","title":"Genetic Signatures - Deal Equates to Issue of 469 Mln New Gss Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669297196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669297196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7048","GSS.AU","BK7124","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196293","title":"Genetic Signatures - Co and Microba Life Sciences Agree to Principal Commercial Terms for Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196293?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7048","GSS.AU","BK7501","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196218","title":"Genetic Signatures - Proposed Merger to be Funded Through Issue of Gss Securities, no Cash Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196218?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033157,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE8TFWSS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","GSS.AU","BK7048","BK7124","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668931922","title":"Genetic Signatures - General Meeting for Considering Resolution That Individual be Removed as Director of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2668931922","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668931922?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:50","pubTimestamp":1789602626,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nFWN4580MU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668319279","title":"Genetic Signatures - Received a Request from BCAL Diagnostics for Directors of Gss to Call and Arrange General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2668319279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668319279?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:50","pubTimestamp":1789602626,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nFWN4580MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","GSS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664236888","title":"BCAL Diagnostics - Requests Removal of Michael Aicher and Appointment of Forrester and Melki to Gss Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2664236888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664236888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:40","pubTimestamp":1788403215,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUEV0GFX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","GSS.AU","BDX.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842699","title":"Genetic Signatures - Requested BCAL Diagnostics to Clarify Details of Its Shareholdings and Associates in Gss","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842699?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:38","pubTimestamp":1788392299,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7048","GSS.AU","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664488217","title":"Genetic Signatures Ltd-Final Director's Interest Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2664488217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664488217?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:12","pubTimestamp":1788228742,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUE8SRT7Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663702681","title":"Genetic Signatures Announces Board Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2663702681","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663702681?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:55","pubTimestamp":1788141352,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Announces Board ChangesAug 31 (Reuters)-Genetic Signatures LtdGSS.AX:BOARD CHANGESMIKE AICHER ASSUMES ROLE OF CHAIR AT GENETIC SIGNATURESCAROLINE WALDRON RESIGNS AS NON-EXECUTIVE CHAIR AND DIRECTOR EFFECTIVE TODAYFurther company coverage:GSS.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE8XYRHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663408180","title":"Genetic Signatures Ltd-Board Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2663408180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663408180?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:39","pubTimestamp":1788129586,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE8XYRHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040356","title":"Genetic Signatures - Caroline Waldron Resigns as Non-Executive Chair and Director Effective Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040356?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:39","pubTimestamp":1788129586,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE8XYRHL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","GSS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663040353","title":"Genetic Signatures - Mike Aicher Assumes Role of Chair at Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2663040353","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663040353?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:39","pubTimestamp":1788129586,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUE8XYRHL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662767137","title":"Australia's Genetic Signatures Climbs on Potential Merger with Microba","url":"https://stock-news.laohu8.com/highlight/detail?id=2662767137","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662767137?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:40","pubTimestamp":1787722801,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures climbs on potential merger with Microba** Shares of Australia's Genetic SignaturesGSS.AXrise as much as 6.9% to A$0.0855, hitting their highest level since May 4** ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4N44N0AX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7124","BK7048","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662476825","title":"Genetic Signatures - Combined Group to Benefit from Streamlined Cost Base and Potential Accelerated Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662476825","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662476825?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:30","pubTimestamp":1787700640,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUENDSZ2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7124","BK7048","BK7501","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662048712","title":"Genetic Signatures Ltd - FY Revenues from Ordinary Activities A$14.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662048712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662048712?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:15","pubTimestamp":1787613347,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0UW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","GSS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258927","title":"Genetic Signatures Ltd-Commercial Testing Commences at Hvidovre Hospital in Denmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258927?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:26","pubTimestamp":1787268401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUE50GHHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}